packageVorinostat

vorinostat

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Vorinostat is a histone deacetylase inhibitor used as an anticancer drug, mainly for cutaneous T-cell lymphoma and studied in other blood cancers such as mycosis fungoides, acute myeloid leukemia, and lymphomas. It is an approved medicine, though an application for one product in the European Union was withdrawn, so its use is mainly outside the EU.

Summary written by glm-5.3-flash from Wikidata Q905901 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:vorinostat
ATC codes:L01XH01
DrugBank:DB02546
PubChem CID:5311
ChEBI:45716
Wikidata:Q905901
formula:C14H20N2O3
molar mass:264.325 g/mol (PubChem CID 5311)
logP:1.9 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown